Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Nov;32(11):2561-5.
doi: 10.1161/ATVBAHA.112.300135.

High density lipoprotein biogenesis, cholesterol efflux, and immune cell function

Affiliations
Review

High density lipoprotein biogenesis, cholesterol efflux, and immune cell function

Mary G Sorci-Thomas et al. Arterioscler Thromb Vasc Biol. 2012 Nov.

Abstract

This review provides a summary of recent research on the role of high-density lipoprotein (HDL)/apolipoprotein A-I cholesterol efflux and immune cell function. Plasma concentrations of HDL have been known to inversely correlate with risk for coronary vascular disease. Bulk transport of HDL cholesterol from the peripheral tissues to the liver is a major pathway, termed reverse cholesterol transport, responsible for maintaining whole body cholesterol homeostasis. In addition to participating in this pathway, HDL and apolipoprotein A-I exert anti-inflammatory effects through different pathways. One pathway that seems to be important in atherosclerosis and autoimmunity is its role in modulation of T cell activation. HDL/apolipoprotein A-I helps regulate cell signaling by accepting membrane cholesterol from ATP binding cassette transporter A1 on immune cells and, thereby, fine tuning the amount of cholesterol present in plasma membrane lipid rafts.

PubMed Disclaimer

Figures

Figure
Figure
A Mechanism for assembling nascent high-density lipoprotein (nHDL) particles. ATP binding cassette transporter (ABC) A1 coordinates the removal of excess membrane free cholesterol (FC) and sphingomyelin (SM) and thus lowers the amount of lipid raft on the plasma membrane. ABCA1 is not located in lipid rafts (regions enriched in FC and SM), but these regions are undoubtedly the source of lipids transferred to nHDL. Biogenesis of nHDL particles by ABCA1 begins when apolipoprotein (apo) A-I binds at the membrane surface, possibly to accessory protein(s), and then moves to ABCA1. If lipid or apoA-I are unavailable then a lipid-poor nHDL of <6 nm diameter is released. If a second apoA-I is added then the newly formed 2-apoA-I/ABCA1 complex can package small amounts of lipid. This complex is either released as a 7.5-nm -diameter nHDL or it adds a third molecule of apoA-I. At this point it can load more lipid to release an ≈9- to 11-nm-diameter nHDL into the medium. Reprinted with permission.

References

    1. Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation. 1977;55:767–772. - PubMed
    1. Duffy D, Rader DJ. Update on strategies to increase HDL quantity and function. Nat Rev Cardiol. 2009;6:455–463. - PubMed
    1. Brown WV, Brewer HB, Rader DJ, Schaefer EJ. HDL as a treatment target. J Clin Lipidol. 2010;4:5–16. - PubMed
    1. Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, Jafri K, French BC, Phillips JA, Mucksavage ML, Wilensky RL, Mohler ER, Rothblat GH, Rader DJ. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med. 2011;364:127–135. - PMC - PubMed
    1. Francis GA. The complexity of HDL. Biochim Biophys Acta. 2010;1801:1286–1293. - PubMed

Publication types

MeSH terms